<! DOCTYPE = html>
<html>
<title>CS657 - Prescription</title>
<style>
div.container {
		width: 100%;
		border: 1px solid gray;
}

header{
		padding: 0.5em;
		#color: black;
		background-color: orange;
		clear: left;
		text-align: center;
}
.footer{
		padding : 1em;
		background-color: orange;
		text-align: center;
		<!--- position: fixed;>
		bottom : 0;
		width : 100%;
}

nav {
		float: left;
		max-width: 160px;
		margin: 0;
		padding: 1em;
}

nav ul {
		list-style-type: none;
		padding: 0;
}
	 
nav ul a {
		text-decoration: none;
}

article {
		margin-left: 170px;
		border-left: 1px solid gray;
		padding: 1em;
		overflow: hidden;
}
table {
		font-family: arial, sans-serif;
		border-collapse: collapse;
		width: 80%;
}

td, th {
		border: 4px solid #000000;
		text-align: middle;
		padding: 8px;
}

tr:nth-child(even) {
		background-color: #eeeeee;
}	

div.box {
		background-color: white;
		width: 300px;
		border: 2px solid green;
		padding: 10px;
		margin: 25px;
}
</style>
<body>
<div class="container">
	<header><h1>
		IIT Kanpur Medical Labs</h1>
	</header>
	<hr>	<h2> Precription for the query: </h2>
	<div class="box">
	memory loss, confusion, depression
	</div>
	<hr>	<h2>
		Identified Disease: </h2>
	<div class="box">
	Alzheimer Disease
	</div>
	<hr>	<h2>More Symptoms: </h2>
	<div class="box">
	Ataxia, Akathisia, Learning Disorders, Headache, Quadriplegia
	</div>
		<hr><h2>
Medication:</h2>
<table>
	<tr>
		<th>Serial No</th>
		<th>Drug Name</th>
		<th>Group</th>
		<th>Indication</th>
	</tr>	<tr>
		<td>1.</td>
		<td>Methylene blue</td>
		<td>Approved, Investigational</td>
		<td>Methylene blue has several indications in medicine:1. found to improve the hypotension associated with various clinical states.2. Antiseptic in urinary tract infections.3. Improves hypoxia and hyper dynamic circulation in cirrhosis of liver and severe hepatopulmonary syndrome.4. Results in transient and reproducible improvement in blood pressure and cardiac function in septic shock.5. Investigated for the treatment of Alzheimer's disease.6. Treatment of ifofosamide induced neurotoxicity.</td>
	</tr>	<tr>
		<td>2.</td>
		<td>KC706</td>
		<td>Investigational</td>
		<td>Investigated for use/treatment in cardiovascular disorders, inflammatory bowel disease, inflammatory disorders (unspecified), psoriasis and psoriatic disorders, and rheumatoid arthritis.</td>
	</tr>	<tr>
		<td>3.</td>
		<td>ADC4022</td>
		<td>Investigational</td>
		<td>Investigated for use/treatment in asthma and chronic obstructive pulmonary disease (COPD).</td>
	</tr>	<tr>
		<td>4.</td>
		<td>FP0011</td>
		<td>Investigational</td>
		<td>Investigated for use/treatment in amyotrophic lateral sclerosis (ALS) and parkinson's disease.</td>
	</tr>	<tr>
		<td>5.</td>
		<td>DLO6002</td>
		<td>Investigational</td>
		<td>Investigated for use/treatment in parkinson's disease.</td>
	</tr>	<tr>
		<td>6.</td>
		<td>DLO6001</td>
		<td>Investigational</td>
		<td>Investigated for use/treatment in parkinson's disease.</td>
	</tr>	<tr>
		<td>7.</td>
		<td>Lexaptepid Pegol</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>8.</td>
		<td>Pozanicline</td>
		<td>Investigational</td>
		<td>Investigated for use/treatment in Alzheimer's disease, Attention Deficit/Hyperactivity Disorder (ADHD), and Schizophrenia and schizoaffective disorders.</td>
	</tr>	<tr>
		<td>9.</td>
		<td>Idazoxan</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>10.</td>
		<td>Semagacestat</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>11.</td>
		<td>Avagacestat</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>12.</td>
		<td>Lecozotan</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>13.</td>
		<td>Begacestat</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>14.</td>
		<td>Cerlapirdine</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>15.</td>
		<td>scyllo-inositol</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>16.</td>
		<td>Aleplasinin</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>17.</td>
		<td>GSI-136</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>18.</td>
		<td>Tricaprylin</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>19.</td>
		<td>L-deprenyl-D2 C-11</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>20.</td>
		<td>Latrepirdine</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>21.</td>
		<td>Talsaclidine</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>22.</td>
		<td>AVE-1625</td>
		<td>Investigational</td>
		<td>Investigated for use/treatment in alzheimer's disease, obesity, and schizophrenia and schizoaffective disorders.</td>
	</tr>	<tr>
		<td>23.</td>
		<td>Vanutide cridificar</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>24.</td>
		<td>Crenezumab</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>25.</td>
		<td>Tideglusib</td>
		<td>Investigational, Withdrawn</td>
		<td>Tideglusib was initially formulated for the treatment of Alzheimer and progressive supranuclear palsy.[1] The raising interest for the use of tideglusib comes from the significant upregulation of GSK-3 in the brain in patients with Alzheimer disease. Its function as a degradant of β-catenin, was also important, as it prevents the transcription of cell survival genes. All these factors have directed current research towards this kinase as a potential target.[3] Alzheimer disease is the most prevalent form of dementia. The most accepted hypothesis to explain this disease is related to the presence of amyloid β, which triggers a cascade that will alter the Tau protein and provoke synaptic dysfunction and neuronal death.[4] GSK-3 importance in the tissue repair pathway has also pointed out a novel application for tideglusib. Thus, it is also under the research for the natural repair treatment of deep caries lesions.[2] </td>
	</tr></table>
<div class="footer"> Copyright &copy : IIT Kanpur
</div>	
</div>
</body>
</html>